Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,375 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mechanical properties and performances of contemporary drug-eluting stent: focus on the metallic backbone.
Chichareon P, Katagiri Y, Asano T, Takahashi K, Kogame N, Modolo R, Tenekecioglu E, Chang CC, Tomaniak M, Kukreja N, Wykrzykowska JJ, Piek JJ, Serruys PW, Onuma Y. Chichareon P, et al. Among authors: chang cc. Expert Rev Med Devices. 2019 Mar;16(3):211-228. doi: 10.1080/17434440.2019.1573142. Epub 2019 Feb 8. Expert Rev Med Devices. 2019. PMID: 30676121 Review.
A prospective multicentre randomised all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale and design of the Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent (TALENT) trial.
Modolo R, Chichareon P, Kogame N, Asano T, Chang CC, de Winter RJ, Kaul U, Zaman A, Spitzer E, Takahashi K, Katagiri Y, Soliman OII, van Es GA, Morel MA, Onuma Y, Serruys PW. Modolo R, et al. Among authors: chang cc. EuroIntervention. 2019 Jul 20;15(4):e362-e369. doi: 10.4244/EIJ-D-18-00499. EuroIntervention. 2019. PMID: 30066672 Free article. Clinical Trial.
Drug-eluting bioresorbable scaffolds in cardiovascular disease, peripheral artery and gastrointestinal fields: a clinical update.
Kawashima H, Ono M, Kogame N, Takahashi K, Chang CC, Hara H, Gao C, Wang R, Tomaniak M, Modolo R, Wykrzykowska JJ, De Winter RJ, Sharif F, Serruys PW, Onuma Y. Kawashima H, et al. Among authors: chang cc. Expert Opin Drug Deliv. 2020 Jul;17(7):931-945. doi: 10.1080/17425247.2020.1764932. Epub 2020 May 27. Expert Opin Drug Deliv. 2020. PMID: 32456554 Review.
Angiography-Derived Fractional Flow Reserve in the SYNTAX II Trial: Feasibility, Diagnostic Performance of Quantitative Flow Ratio, and Clinical Prognostic Value of Functional SYNTAX Score Derived From Quantitative Flow Ratio in Patients With 3-Vessel Disease.
Asano T, Katagiri Y, Chang CC, Kogame N, Chichareon P, Takahashi K, Modolo R, Tenekecioglu E, Collet C, Jonker H, Appleby C, Zaman A, van Mieghem N, Uren N, Zueco J, Piek JJ, Reiber JHC, Farooq V, Escaned J, Banning AP, Serruys PW, Onuma Y. Asano T, et al. Among authors: chang cc. JACC Cardiovasc Interv. 2019 Feb 11;12(3):259-270. doi: 10.1016/j.jcin.2018.09.023. JACC Cardiovasc Interv. 2019. PMID: 30409759 Free article.
Impact of post-procedural minimal stent area on 2-year clinical outcomes in the SYNTAX II trial.
Katagiri Y, De Maria GL, Kogame N, Chichareon P, Takahashi K, Chang CC, Modolo R, Walsh S, Sabate M, Davies J, Lesiak M, Moreno R, Cruz-Gonzalez I, West NEJ, Piek JJ, Wykrzykowska JJ, Farooq V, Escaned J, Banning AP, Onuma Y, Serruys PW. Katagiri Y, et al. Among authors: chang cc. Catheter Cardiovasc Interv. 2019 Mar 1;93(4):E225-E234. doi: 10.1002/ccd.28105. Epub 2019 Jan 31. Catheter Cardiovasc Interv. 2019. PMID: 30702187 Clinical Trial.
Two years clinical outcomes with the state-of-the-art PCI for the treatment of bifurcation lesions: A sub-analysis of the SYNTAX II study.
Modolo R, Kogame N, Komiyama H, Chichareon P, de Vries T, Tomaniak M, Chang CC, Takahashi K, Walsh S, Lesiak M, Moreno R, Farrooq V, Escaned J, Banning A, Onuma Y, Serruys PW. Modolo R, et al. Among authors: chang cc. Catheter Cardiovasc Interv. 2020 Jul;96(1):10-17. doi: 10.1002/ccd.28422. Epub 2019 Aug 12. Catheter Cardiovasc Interv. 2020. PMID: 31402574
Clinical relevance of ticagrelor monotherapy following 1-month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial.
Kogame N, Chichareon P, De Wilder K, Takahashi K, Modolo R, Chang CC, Tomaniak M, Komiyama H, Chieffo A, Colombo A, Garg S, Louvard Y, Jüni P, G Steg P, Hamm C, Vranckx P, Valgimigli M, Windecker S, Stoll HP, Onuma Y, Janssens L, Serruys PW. Kogame N, et al. Among authors: chang cc. Catheter Cardiovasc Interv. 2020 Jul;96(1):100-111. doi: 10.1002/ccd.28428. Epub 2019 Aug 13. Catheter Cardiovasc Interv. 2020. PMID: 31410968 Clinical Trial.
Impact of established cardiovascular disease on outcomes in the randomized global leaders trial.
Garg S, Chichareon P, Kogame N, Takahashi K, Modolo R, Chang CC, Tomaniak M, Fath-Ordoubadi F, Anderson R, Oldroyd KG, Stables RH, Kukreja N, Chowdhary S, Galasko G, Hoole S, Zaman A, Hamm CW, Steg PG, Jüni P, Valgimigli M, Windecker S, Onuma Y, Serruys PW. Garg S, et al. Among authors: chang cc. Catheter Cardiovasc Interv. 2020 Dec;96(7):1369-1378. doi: 10.1002/ccd.28649. Epub 2019 Dec 19. Catheter Cardiovasc Interv. 2020. PMID: 31854112 Clinical Trial.
Predicting 2-year all-cause mortality after contemporary PCI: Updating the logistic clinical SYNTAX score.
Chichareon P, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang CC, Tomaniak M, Yuan J, Xie L, Song Y, Qiao S, Yang Y, Guan C, Zurakowski A, van Geuns RJ, Sabate M, Ong PJ, Wykrzykowska JJ, Piek JJ, Garg S, Hamm C, Steg G, Vranckx P, Valgimigli M, Windecker S, Juni P, Onuma Y, Steyerberg E, Xu B, Serruys PW. Chichareon P, et al. Among authors: chang cc. Catheter Cardiovasc Interv. 2021 Dec 1;98(7):1287-1297. doi: 10.1002/ccd.29490. Epub 2021 Feb 4. Catheter Cardiovasc Interv. 2021. PMID: 33539048
Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial.
Katagiri Y, Onuma Y, Lurz P, Buszman P, Piek JJ, Wykrzykowska JJ, Asano T, Kogame N, Takahashi K, Chang CC, de Winter RJ, Serruys PW, Wijns W; Collaborators. Katagiri Y, et al. Among authors: chang cc. EuroIntervention. 2020 Feb 7;15(15):e1366-e1374. doi: 10.4244/EIJ-D-18-00944. EuroIntervention. 2020. PMID: 30719981 Free article. Clinical Trial.
5,375 results